Check the person.
Check the product.

Arizona licence tools checked October 3, 2026.

MD · medical doctor

The Arizona Medical Board’s Doctor Search shows licence details and public board orders. An order is a written decision the board makes about a doctor.

Read an order to see what action the board took and whether it placed limits on the doctor’s work.

Look up an MD

DO · another type of medical doctor

DO stands for doctor of osteopathic medicine. This is another type of medical doctor. Arizona’s separate Osteopathic Board has the licence search for these doctors.

Look up a DO

NP · nurse practitioner

Nurse practitioners are nurses with added training for a wider care role. The Arizona Nursing Board’s links let you check the nurse’s licence and the extra certificate that covers that role.

In Arizona, a nurse practitioner can make care decisions. Prescribing medicine also requires the board’s permission for the patient group covered by the nurse’s training.

Ask the board how to check this nurse’s permission to prescribe for your care.

Open the nursing licence and certificate checks

PA · physician assistant

A physician assistant provides medical care as a health professional. Arizona’s PA Board has the licence search for this role.

An Arizona PA’s prescribing role depends on training and skill. The board’s count of clinical work hours determines whether an agreement with a supervising doctor is required.

Ask about the PA’s prescribing role and any required agreement with a supervising doctor.

Open the PA licence search

Arizona law, as of October 6, 2026, limits some records of board action on a clinician’s conduct or practice to five years on board websites.

These include disciplinary actions, meaning steps a board takes over a problem, and final decisions that do not impose discipline.

Dismissed complaints and letters raising concerns or giving advice have separate limits on what appears on a board website.

Written records of public board meetings, called minutes, and meeting notices do not have that five-year website limit when the law requires the board to keep them.

A blank online record does not prove that no past complaint or board action exists.

You can ask the clinician’s licensing board for extra public records beyond what its website shows.

Ask for available older records of board action and public meeting records about that clinician. The board can explain which records it can release.

Rules for Arizona pharmacies, checked October 3, 2026.

Preparing a medicine to meet a particular patient’s need is called compounding.

An out-of-state pharmacy must have permission from its home state and an Arizona permit to send medicine here.

The pharmacy’s permit and the pharmacist’s personal licence are separate checks.

The permit check is about the pharmacy. The exact medicine it mixes must also meet state and federal rules.

Ask the pharmacist what ingredient is being used and which rules permit the pharmacy to prepare this exact medicine.

The federal Food and Drug Administration (FDA) directs readers to pharmacy licence records at the state level.

Medicines mixed to order do not have FDA approval.

If a public search leaves the permit unclear, ask the Pharmacy Board how to verify it.

Federal product checks as of September 26, 2026.

“FDA registered” means a business has been entered on FDA’s records. A drug may have an entry in the drug list as well. Neither entry means FDA approved the medicine or that it may legally be sold.

A number in FDA’s drug list, called a National Drug Code or NDC, is not proof that FDA approved the medicine.

If an offer shows that number or a place in the drug list, ask to see the actual approval record.

Ask to see the actual study paper or FDA label. Was the evidence from people, animals, or laboratory work?

Did the study test the same ingredient, form, and medical problem? What benefit was measured, and what harms were reported?

BPC-157 is a peptide ingredient offered in products as medicine. At the September 26, 2026 check, no medicine containing it had FDA approval in the U.S.

FDA had too little safety information from people about the ways BPC-157 might be given. It could not judge whether those methods would cause harm.

Ask whether the offer means a shot, a nasal spray, or another way of giving it. The method is part of the question about harm.

Two drug ingredients are called retatrutide and cagrilintide. No FDA-approved medicine contains either one, and neither has been shown to be safe and effective for any condition.

Retatrutide is being studied as a possible weight-loss treatment.

If either name appears in an offer, ask what problem the offer claims to treat. The ingredient’s name does not explain its purpose.

At the September 26, 2026 check, FDA said that using retatrutide or cagrilintide in medicines mixed to order was not allowed under federal law.

Ask the clinician to explain how the evidence fits the treatment being offered to you.